ArticleCell & bioscience2021

Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK.

Kun-Ling Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.